What question did this study set out to answer?

This research aims to determine how SLC25A20 influences energy metabolism and tumor growth in lung adenocarcinoma.

July 26, 2026Cell Death and DiseaseOpen Access

SLC25A20 promotes tumor growth by reprogramming energy metabolism in lung adenocarcinoma

View Full Paper

Ask AI

Bookmark

This research aims to determine how SLC25A20 influences energy metabolism and tumor growth in lung adenocarcinoma.
Examined SLC25A20 expression in lung adenocarcinoma tissues and cells.
Conducted gain- and loss-of-function experiments to assess effects on tumor cell behaviors.
Used pharmacological inhibition and genetic silencing in vivo to evaluate tumor growth impact.
SLC25A20 upregulation correlated with poor patient survival in lung adenocarcinoma (LUAD) patients.
Inhibition of SLC25A20 impaired tumor cell proliferation and migration.
SLC25A20 supports mitochondrial bioenergetics and oxidative phosphorylation, sustaining tumor growth.

No takes yet. Share an insight, caveat, or question.

Randomized trial uncovers SLC25A20's role in enhancing tumor growth in lung adenocarcinoma, suggesting a potential treatment target.

Liu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark